von Hippel–Lindau protein promotes Skp2 destabilization on DNA damage
Oncogene, 03/10/2011

1 Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer Journal of the National Cancer Institute, May 1, 2013    Clinical Article

2 Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma British Journal of Cancer, May 23, 2013

3 Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial The Lancet Oncology, May 3, 2013    Clinical Article

4 Gleason 6 prostate tumors diagnosed in the PSA era do not demonstrate the capacity for metastatic spread at the time of radical prostatectomy Urology, May 28, 2013    Clinical Article

5 NF-kB Inhibition by Bortezomib Permits Interferon-γ-Activated RIP1 Kinase-Dependent Necrosis in Renal Cell Carcinoma. Molecular Cancer Therapeutics, May 13, 2013    Clinical Article

6 Assessing the invasive potential of bladder cancer: development and validation of a new preclinical assay The Journal of Urology, May 7, 2013    Clinical Article

7 Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma The Journal of Urology, May 13, 2013    Clinical Article

8 Outcomes in stage I testicular seminoma: A population-based study of 9193 patients Cancer, May 6, 2013    Clinical Article

9 PSA screening and deaths from prostate cancer after diagnosis—a population based analysis The Prostate, May 7, 2013    Clinical Article

10 Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy British Journal of Cancer, May 6, 2013    Clinical Article

11 Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide Annals of Oncology, April 19, 2013    Clinical Article

12 Fibroblast Growth Factor Receptor 3 is a Rational Therapeutic Target in Bladder Cancer Molecular Cancer Therapeutics, May 13, 2013    Clinical Article

13 Treatment of local-regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors British Journal of Cancer, May 17, 2013

14 Relationship of gleason patterns in gleason score 7 prostate cancer Cancer Research, May 24, 2013    Clinical Article

15 Intrinsic immune alterations in renal cell carcinoma and emerging immunotherapeutic approaches Expert Opinion on Biological Therapy, May 30, 2013    Review Article

16 Safety and toxicity of saw palmetto in the camus trial The Journal of Urology, April 22, 2013    Clinical Article

17 A phase II trial of neoadjuvant nab-paclitaxel, carboplatin, and gemcitabine (ACAG) in patients with locally advanced carcinoma of the bladder Urology, May 24, 2013    Clinical Article

18 Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors British Journal of Cancer, May 13, 2013    Clinical Article

19 Associations of tea and coffee consumption with prostate cancer risk Cancer Causes and Control, April 23, 2013    Clinical Article

20 Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike Medical Oncology, April 30, 2013    Clinical Article